Pesser Niels, Bode Aron, Goeteyn Jens, Hendriks Joris, van Nuenen Bart F L, Illig Karl A, van Sambeek Marc R H M, Teijink Joep A W
Department of Vascular Surgery, Catharina Hospital, Eindhoven.
Department of Radiology, Catharina Hospital, Eindhoven.
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1159-1167.e2. doi: 10.1016/j.jvsv.2020.12.079. Epub 2021 Jan 8.
Venous thoracic outlet syndrome (VTOS) is considered chronic when symptoms and venous stenosis or occlusion are present for >3 months after the initial primary upper extremity deep vein thrombosis event. Many of patients with chronic VTOS receive conservative treatment. However, a subset of these patients will have persistent post-thrombotic syndrome symptoms because of underlying causative anatomy. We present the results of a same admission treatment consisting of' transaxillary thoracic outlet decompression (TA-TOD), external venolysis, and, if necessary, treatment of residual intraluminal lesions with percutaneous transluminal angioplasty (PTA) for chronic VTOS.
All patients presenting from January 2015 to December 2019 with chronic VTOS and post-thrombotic syndrome complaints were evaluated. Patients with some degree of patency on venography or a chronic occlusion that could be recanalized using PTA preoperatively underwent TA-TOD, external venolysis, and immediate venography. Low-pressure diagnostic balloon inflation after first rib resection was used to identify residual lesions not evident by venography. If found, PTA was performed. Stent placement was reserved for patients with recurrent complaints due to residual lesions that had not been effectively treated by PTA.
A total of 40 patients with chronic VTOS were evaluated, of whom 36 were included and treated according to the protocol. The remaining four patients had had a chronic occlusion that could not be recanalized preoperatively and these patients were, therefore, excluded. After TA-TOD, immediate venography showed patent vessels with residual stenosis in 31 patients. Of the five patients who had appeared to have no significant stenosis on venography, two showed narrowing with diagnostic balloon inflation of the subclavian vein, for a total of 33 patients (92%) with residual stenosis after TA-TOD. All 33 patients underwent formal venous PTA. Complications occurred in five patients. At a mean follow-up of 24 months, 30 of the 36 patients (83%) were free of symptoms. The mean thoracic outlet syndrome disability scale score was 1.97 ± 1.9. The mean Disability of the Arm Shoulder and Hand scale score was 16.16 ± 17.4. The median VEINES (venous insufficiency epidemiologic and economic study)-symptoms score was 53.90 (interquartile range, 10.54). The median VEINES-quality of life (QOL) score was 54.22 (interquartile range, 13.93). Finally, the mean 12-item short-form physical QOL component scale score was 47.97 ± 9.02. The thoracic outlet syndrome disability scale and Disability of the Arm Shoulder and Hand scale scores had significantly decreased (P < .01), and the 12-item short-form physical QOL component scale score had significantly improved (P < .01) compared with the baseline scores. A return to daily activities was achieved by 93% of the patients.
The treatment of patients with chronic VTOS using a same admission treatment algorithm consisting of TA-TOD, external venolysis, and PTA is effective. Intermediate follow-up showed a high return to daily activity and significant improvement in functional outcome and physical QOL.
当初次原发性上肢深静脉血栓形成事件后症状及静脉狭窄或闭塞持续超过3个月时,静脉型胸廓出口综合征(VTOS)被视为慢性疾病。许多慢性VTOS患者接受保守治疗。然而,由于潜在的致病解剖结构,这些患者中有一部分会出现持续的血栓后综合征症状。我们展示了一种针对慢性VTOS的同期入院治疗结果,该治疗包括经腋路胸廓出口减压术(TA-TOD)、体外静脉松解术,必要时用经皮腔内血管成形术(PTA)治疗残留的管腔内病变。
对2015年1月至2019年12月期间出现慢性VTOS并伴有血栓后综合征症状的所有患者进行评估。术前静脉造影显示有一定程度通畅或慢性闭塞且可通过PTA再通的患者接受TA-TOD、体外静脉松解术及即刻静脉造影。在第一肋切除后使用低压诊断性球囊扩张来识别静脉造影未显示的残留病变。若发现残留病变,则进行PTA。对于因残留病变导致反复出现症状且PTA未能有效治疗的患者,进行支架置入。
共评估了40例慢性VTOS患者,其中36例按照方案纳入并接受治疗。其余4例患者存在术前无法再通的慢性闭塞,因此被排除。TA-TOD后,即刻静脉造影显示31例患者血管通畅但有残留狭窄。在静脉造影显示无明显狭窄的5例患者中,2例在锁骨下静脉诊断性球囊扩张时显示狭窄,TA-TOD后共有33例患者(92%)存在残留狭窄。所有33例患者均接受了正规的静脉PTA。5例患者出现并发症。平均随访24个月时,36例患者中有30例(83%)无症状。胸廓出口综合征残疾量表平均评分为1.97±1.9。手臂、肩部和手部残疾量表平均评分为16.16±17.4。静脉功能不全流行病学和经济学研究(VEINES)症状评分中位数为53.90(四分位间距为10.54)。VEINES生活质量(QOL)评分中位数为54.22(四分位间距为13.93)。最后,12项简短形式身体QOL分量表平均评分为47.97±9.02。与基线评分相比,胸廓出口综合征残疾量表和手臂、肩部和手部残疾量表评分显著降低(P<.01),12项简短形式身体QOL分量表评分显著改善(P<.01)。93%的患者恢复了日常活动。
采用由TA-TOD、体外静脉松解术和PTA组成的同期入院治疗方案治疗慢性VTOS患者是有效的。中期随访显示患者恢复日常活动的比例较高,功能结局和身体QOL有显著改善。